cardiovascular disease treatment

New Nanoparticle Can Treat Cardiovascular Disease

harminka — Thu, 04 Jun 2009 14:35:12 -0500

Scientists and engineers at UC Santa Barbara and other researchers have developed a nanoparticle that can attack plaque –– a major cause of cardiovascular disease. The new development is described in a recent issue of the Proceedings of the National Academy of Sciences.

New risk factor for cardiovascular disease discovered

harminka — Mon, 10 Nov 2008 01:18:22 -0600

A team of international researchers – including scientists from the McGill University Health Centre (MUHC) and McGill University – have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease. The results of the study were so conclusive that the clinical trial had to be stopped before its scheduled completion date.

WFU researchers discover new hemoglobin function

harminka — Mon, 05 Nov 2007 09:42:49 -0600

A team of researchers from Wake Forest University, the National Institutes of Health and other institutions has discovered a previously undetected chemical process within the oxygen-carrying molecule hemoglobin that could have far-reaching implications for the treatment of cardiovascular diseases.

Renal transplant recipients’ genetic makeup does not impact fluvastatin use

harminka — Tue, 28 Aug 2007 05:53:42 -0500

Scientists report that when people with a transplanted kidney take fluvastatin, a drug against cardiovascular disease, their response to the drug is not influenced by their genetic composition.

Early treatment can reverse heart damage

harminka — Mon, 27 Aug 2007 13:10:25 -0500

University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.

Drug interactions with warfarin

harminka — Tue, 14 Aug 2007 02:10:05 -0500

Anticoagulants (e.g., warfarin) and antiplatelet drugs (e.g., acetylsalicylic acid) are key therapeutic agents in the treatment of cardiovascular diseases.